|Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era|
D Chalmers, D Nicol, J Kaye, J Bell, AV Campbell, CWL Ho, K Kato, ...
BMC medical ethics 17 (1), 1-14, 2016
|Community engagement for big epidemiology: deliberative democracy as a tool|
RE McWhirter, CR Critchley, D Nicol, D Chalmers, T Whitton, M Otlowski, ...
Journal of personalized medicine 4 (4), 459-474, 2014
|Understanding public reactions to commercialization of biobanks and use of biobank resources|
D Nicol, C Critchley, R McWhirter, T Whitton
Social science & medicine 162, 79-87, 2016
|Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic|
D Nicol, L Eckstein, M Morrison, JS Sherkow, M Otlowski, T Whitton, ...
Genome medicine 9 (1), 1-4, 2017
|Are the gene-patent storm clouds dissipating? A global snapshot|
J Liddicoat, T Whitton, D Nicol
Nature biotechnology 33 (4), 347-352, 2015
|New avenues within community engagement: addressing the ingenuity gap in our approach to health research and future provision of health care|
D Chalmers, RE McWhirter, D Nicol, T Whitton, M Otlowski, MM Burgess, ...
Journal of Responsible Innovation 1 (3), 321-328, 2014
|Public interest, health research and data protection law: Establishing a legitimate trade-off between individual control and research access to health data|
MJ Taylor, T Whitton
Laws 9 (1), 6, 2020
|The innovation pool in biotechnology: the role of patents in facilitating innovation|
D Nicol, JL Nielsen, J Liddicoat, C Critchley, T Whitton
Available at SSRN 2503314, 2014
|Provenance and risk in transfer of biological materials|
J Nielsen, T Bubela, DRC Chalmers, A Johns, L Kahl, J Kamens, ...
PLoS biology 16 (8), e2006031, 2018
|Another missed opportunity to reform compulsory licensing and Crown use in Australia|
JL Nielsen, D Nicol, J Liddicoat, T Whitton
|Terms of Engagement: Transfer of Biological Materials for Research in Australia.|
T Whitton, J Nielsen, D Nicol
Journal of law and Medicine 27 (2), 338-354, 2019
|My Way or the MTA: The Use of Material Transfer Agreements in Publicly Funded Research in Australia|
J Nielsen, D Nicol, TC Whitton, D Chalmers
|Comments on Draft R & D BluePrint MTA Tool|
D Nicol, J Nielsen, D Chalmers, T Whitton
|Human embryos, genome editing and future directions|
TC Whitton, D Nicol, DRC Chalmers
The Federation Press, 2017
|The Innovation Pool in Biotechnology: the Role of Patents in Facilitating Innovation, Occasional Paper No. 8|
D Nicol, JL Nielsen, JE Liddicoat, CR Critchley, TC Whitton